Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac G sα Overexpression
- 1 April 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 78 (4) , 517-524
- https://doi.org/10.1161/01.res.78.4.517
Abstract
To study the physiological effect of the overexpression of myocardial Gsα (protein levels increased by approximately threefold in transgenic mice), we examined the responsiveness to sympathomimetic amines by echocardiography (9 MHz) in five transgenic mice and five control mice (both 10.3±0.2 months old). Myocardial contractility in transgenic mice, as assessed by left ventricular (LV) fractional shortening (LVFS) and LV ejection fraction (LVEF), was not different from that of control mice at baseline (LVFS, 40±3% versus 36±2%; LVEF, 78±3% versus 74±3%). LVFS and LVEF values in transgenic mice during isoproterenol (ISO, 0.02 μg/kg per minute) infusion were higher than the values in control mice (LVFS, 68±4% versus 48±3%; LVEF, 96±1% versus 86±3%; P<.05). Norepinephrine (NE, 0.2 μg/kg per minute) infusion also increased LVFS and LVEF in transgenic mice more than in control mice (LVFS, 59±4% versus 47±3%; LVEF, 93±2% versus 85±3%; P<.05). Heart rates of transgenic mice were higher than those of control mice during ISO and NE infusion. In three transgenic mice with heart rates held constant, LV dP/dt rose by 33±2% with ISO (0.02 μg/kg per minute) and by only 13±2% in three wild-type control mice (P<.01). NE (0.1 μg/kg per minute) also induced a greater effect on LV dP/dt in the three transgenic mice with heart rates held constant compared with three wild-type control mice (65±8% versus 28±4%, P<.05). Pathological and histological analyses of older transgenic mouse hearts (16.0±0.8 months old) revealed hypertrophy, degeneration, atrophy of cells, and replacement fibrosis reflected by significant increases in collagen volume in the subendocardium (5.2±1.4% versus 1.2±0.3%, P<.05) and in the cross-sectional area of myocytes (298±29 versus 187±12 μm2, P<.05) compared with control mouse hearts. These results suggest that Gsα overexpression enhances the efficacy of the β-adrenergic receptor–Gs–adenylyl cyclase signaling pathway. This in turn leads to augmented inotropic and chronotropic responses to endogenous sympathetic stimulation. This action over the life of the animal results in myocardial damage characterized by cellular degeneration, necrosis, and replacement fibrosis, with the remaining cells undergoing compensatory hypertrophy. As a model, this transgenic mouse offers new insights into the mechanisms of cardiomyopathy and heart failure and provides a new tool for their study.Keywords
This publication has 16 references indexed in Scilit:
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Overexpression of Gs alpha protein in the hearts of transgenic mice.Journal of Clinical Investigation, 1995
- Adenylyl cyclases and the interaction between calcium and cAMP signallingNature, 1995
- Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1994
- Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic ReceptorScience, 1994
- Specific atrial overexpression of G protein coupled human 1 adrenoceptors in transgenic miceCardiovascular Research, 1993
- Antisense oligodeoxynucleotides to Gs protein α-subunit sequence accelerate differentiation of fibroblasts to adipocytesNature, 1992
- Xamoterol in severe heart failureThe Lancet, 1990
- Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failureAmerican Heart Journal, 1986
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982